Husqvarna AB: Invitation – second quarter results presentation
Alfa Laval: Invitation to Alfa Laval’s Second-Quarter Conference Call
Orexo signs license agreement with Mundipharma, which obtains ex-US global rights to Zubsolv®
Increased Number of Shares and Votes in Castellum
Eutelsat Communications: New Strategic Priorities and Financial Objectives
SCA: Invitation to SCA’s Q2 2016 Press Conference
GlycoMimetics’ GMI-1271 Yields High Remission Rates and Favorable Tolerability in Phase 1 Portion of Phase 1/2 Clinical Trial for AML
Realizing a huge capital gain has put this closed-end fund's share price and discount in the spotlight.
Proper comparisons can help you avoid missteps.
Closed-end funds aren?t very popular these days, especially when compared with their well-known cousins, open-end funds (which are more commonly known as mutual funds). However, closed-end funds have actually been around longer, and they have some benefits that make them worth a look--as well as ...